Public-registry trials using Bimatoprost Ophthalmic that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients | Laboratoires Thea | Glaucoma | PHASE3 | 64 |
| First registered study | September 2005 — NCT00187577 (University of California, San Francisco) |
| Registered studies matching this name | 142 all-time · 7 currently recruiting |
Source: ClinicalTrials.gov, the public trial registry.
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
← Eichor home · All tracked trials · Glaucoma studies · Weekly briefs